Evolus Inc
For the period ended Mar 31, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 7, 2025
EOLS$6.81-2.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations and Comprehensive Loss
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Revenue: | ||
| Product revenue, net | $68,074 | $58,964 |
| Service revenue | 448 | 369 |
| Total net revenues | 68,522 | 59,333 |
| Cost of goods sold | 21,867 | 18,830 |
| Gross profit | 46,655 | 40,503 |
| Operating expenses: | ||
| Selling, general and administrative | 56,640 | 45,123 |
| Research and development | 2,212 | 2,078 |
| Revaluation of contingent royalty obligation payable to Evolus Founders | 2,151 | 1,578 |
| Depreciation and amortization | 824 | 646 |
| Total operating expenses | 61,827 | 49,425 |
| Loss from operations | (15,172) | (8,922) |
| Other income (expense): | ||
| Interest income | 710 | 517 |
| Interest expense | (4,415) | (4,702) |
| Other income, net | 57 | 45 |
| Loss before income taxes: | (18,820) | (13,062) |
| Income tax expense | 72 | 47 |
| Net loss | $(18,892) | (13,109) |
| Other comprehensive loss: | ||
| Unrealized income (loss), net of tax | 66 | (130) |
| Comprehensive loss | $(18,826) | $(13,239) |
| Net loss per share, basic and diluted | $(0.30) | $(0.22) |
| Weighted-average shares outstanding used to compute basic and diluted net loss per share | 63,696,627 | 58,797,311 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.